87 related articles for article (PubMed ID: 17414604)
21. Germline novel MSH2 deletions and a founder MSH2 deletion associated with anticipation effects in HNPCC.
Stella A; Surdo NC; Lastella P; Barana D; Oliani C; Tibiletti MG; Viel A; Natale C; Piepoli A; Marra G; Guanti G
Clin Genet; 2007 Feb; 71(2):130-9. PubMed ID: 17250661
[TBL] [Abstract][Full Text] [Related]
22. A novel missense MSH2 gene mutation in a patient of a Korean family with hereditary nonpolyposis colorectal cancer.
Park SJ; Lee KA; Park TS; Kim NK; Song J; Kim BY; Choi JR
Cancer Genet Cytogenet; 2008 Apr; 182(2):136-9. PubMed ID: 18406877
[TBL] [Abstract][Full Text] [Related]
23. A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer.
Froggatt NJ; Green J; Brassett C; Evans DG; Bishop DT; Kolodner R; Maher ER
J Med Genet; 1999 Feb; 36(2):97-102. PubMed ID: 10051005
[TBL] [Abstract][Full Text] [Related]
24. Homozygosity of MSH2 c.1906G-->C germline mutation is associated with childhood colon cancer, astrocytoma and signs of Neurofibromatosis type I.
Toledano H; Goldberg Y; Kedar-Barnes I; Baris H; Porat RM; Shochat C; Bercovich D; Pikarsky E; Lerer I; Yaniv I; Abeliovich D; Peretz T
Fam Cancer; 2009; 8(3):187-94. PubMed ID: 19101824
[TBL] [Abstract][Full Text] [Related]
25. A founder mutation of the MSH2 gene and hereditary nonpolyposis colorectal cancer in the United States.
Lynch HT; Coronel SM; Okimoto R; Hampel H; Sweet K; Lynch JF; Barrows A; Wijnen J; van der Klift H; Franken P; Wagner A; Fodde R; de la Chapelle A
JAMA; 2004 Feb; 291(6):718-24. PubMed ID: 14871915
[TBL] [Abstract][Full Text] [Related]
26. Mutation spectrum in HNPCC in the Israeli population.
Goldberg Y; Porat RM; Kedar I; Shochat C; Sagi M; Eilat A; Mendelson S; Hamburger T; Nissan A; Hubert A; Kadouri L; Pikarski E; Lerer I; Abeliovich D; Bercovich D; Peretz T
Fam Cancer; 2008; 7(4):309-17. PubMed ID: 18389388
[TBL] [Abstract][Full Text] [Related]
27. Localization of cancer susceptibility genes by genome-wide single-nucleotide polymorphism linkage-disequilibrium mapping.
Mitra N; Ye TZ; Smith A; Chuai S; Kirchhoff T; Peterlongo P; Nafa K; Phillips MS; Offit K; Ellis NA
Cancer Res; 2004 Nov; 64(21):8116-25. PubMed ID: 15520224
[TBL] [Abstract][Full Text] [Related]
28. Genetic factors and colorectal cancer in Ashkenazi Jews.
Locker GY; Lynch HT
Fam Cancer; 2004; 3(3-4):215-21. PubMed ID: 15516844
[TBL] [Abstract][Full Text] [Related]
29. GREM1 germline mutation screening in Ashkenazi Jewish patients with familial colorectal cancer.
Laitman Y; Jaeger E; Katz L; Tomlinson I; Friedman E
Genet Res (Camb); 2015 May; 97():e11. PubMed ID: 25992589
[TBL] [Abstract][Full Text] [Related]
30. Partial duplication of MSH2 spanning exons 7 through 14 in Lynch syndrome.
Shiozawa M; Miyakura Y; Tahara M; Morishima K; Kumano H; Koinuma K; Horie H; Lefor AT; Sata N; Yasuda Y; Gonda K; Takenoshita S; Tamura A; Fukushima N; Sugano K
J Gastroenterol; 2013 Jun; 48(6):770-6. PubMed ID: 23595612
[TBL] [Abstract][Full Text] [Related]
31. Confirmation of damaging effect of MSH2 c.2634+1G>C mutation on splicing, its classification and implications for counseling.
Rakobradović J; Krivokuća A; Jovandić S; Kesić V; Branković-Magić M
Cancer Genet; 2019 Nov; 239():1-7. PubMed ID: 31437759
[TBL] [Abstract][Full Text] [Related]
32. Papillary serous carcinoma in situ in ovarian endometriosis in an MSH2 mutation carrier.
Vaknin Z; Gotlieb WH; Arseneau J; Ferenczy A
Int J Gynaecol Obstet; 2009 Oct; 107(1):68-9. PubMed ID: 19545867
[No Abstract] [Full Text] [Related]
33. A Novel Splice-Site Mutation in
Li J; Li Y; Ni H; Yang Z; Chen J; Li Y; Ding S; Jiang X; Wang M; Li L; Lv X; Ruan X; Jiang Q; Lei Z; Cheng Y; Huang J; Deng A
Front Oncol; 2020; 10():983. PubMed ID: 32637358
[TBL] [Abstract][Full Text] [Related]
34. Risk of Metachronous Colorectal Neoplasm after a Segmental Colectomy in Lynch Syndrome Patients According to Mismatch Repair Gene Status.
Quezada-Diaz FF; Hameed I; von Mueffling A; Salo-Mullen EE; Catalano A; Smith JJ; Weiser MR; Garcia-Aguilar J; Stadler ZK; Guillem JG
J Am Coll Surg; 2020 Apr; 230(4):669-675. PubMed ID: 32007537
[TBL] [Abstract][Full Text] [Related]
35. Hereditary cancer screening: Case reports and review of literature on ten Ashkenazi Jewish founder mutations.
Cox DM; Nelson KL; Clytone M; Collins DL
Mol Genet Genomic Med; 2018 Nov; 6(6):1236-1242. PubMed ID: 30152102
[TBL] [Abstract][Full Text] [Related]
36. An Ashkenazi founder mutation in the MSH6 gene leading to HNPCC.
Goldberg Y; Porat RM; Kedar I; Shochat C; Galinsky D; Hamburger T; Hubert A; Strul H; Kariiv R; Ben-Avi L; Savion M; Pikarsky E; Abeliovich D; Bercovich D; Lerer I; Peretz T
Fam Cancer; 2010 Jun; 9(2):141-50. PubMed ID: 19851887
[TBL] [Abstract][Full Text] [Related]
37. Single-amplicon MSH2 A636P mutation testing in Ashkenazi Jewish patients with colorectal cancer: role in presurgical management.
Guillem JG; Glogowski E; Moore HG; Nafa K; Markowitz AJ; Shia J; Offit K; Ellis NA
Ann Surg; 2007 Apr; 245(4):560-5. PubMed ID: 17414604
[TBL] [Abstract][Full Text] [Related]
38. A636P is associated with early-onset colon cancer in Ashkenazi Jews.
Guillem JG; Rapaport BS; Kirchhoff T; Kolachana P; Nafa K; Glogowski E; Finch R; Huang H; Foulkes WD; Markowitz A; Ellis NA; Offit K
J Am Coll Surg; 2003 Feb; 196(2):222-5. PubMed ID: 12595050
[TBL] [Abstract][Full Text] [Related]
39. A636P testing in Ashkenazi Jews.
Guillem JG; Moore HG; Palmer C; Glogowski E; Finch R; Nafa K; Markowitz AJ; Offit K; Ellis NA
Fam Cancer; 2004; 3(3-4):223-7. PubMed ID: 15516845
[TBL] [Abstract][Full Text] [Related]
40. The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population.
Foulkes WD; Thiffault I; Gruber SB; Horwitz M; Hamel N; Lee C; Shia J; Markowitz A; Figer A; Friedman E; Farber D; Greenwood CM; Bonner JD; Nafa K; Walsh T; Marcus V; Tomsho L; Gebert J; Macrae FA; Gaff CL; Paillerets BB; Gregersen PK; Weitzel JN; Gordon PH; MacNamara E; King MC; Hampel H; De La Chapelle A; Boyd J; Offit K; Rennert G; Chong G; Ellis NA
Am J Hum Genet; 2002 Dec; 71(6):1395-412. PubMed ID: 12454801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
